SEARCH

SEARCH BY CITATION

References

  • 1
    Mohamed FA. On Bright's disease, and its essential symptoms. Lancet 1879;1:399401.
  • 2
    Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951;41:27981.
  • 3
    Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999;131:713.
  • 4
    Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986;235:74754.
  • 5
    Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 2000;283:240410.
  • 6
    Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:154651.
  • 7
    Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005;96:48995.
  • 8
    Ndrepepa G, Braun S, Haase HU, Schulz S, Ranftl S, Hadamitzky M et al. Prognostic value of uric acid in patients with acute coronary syndromes. Am J Cardiol 2012;109:12605.
  • 9
    Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988;224:54955.
  • 10
    Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34:14450.
  • 11
    Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998;29:6359.
  • 12
    Suliman ME, Johnson RJ, Garcia-Lopez E, Qureshi AR, Molinaei H, Carrero JJ et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006;48:76171.
  • 13
    Torun M, Yardim S, Simsek B, Burgaz S. Serum uric acid levels in cardiovascular diseases. J Clin Pharm Ther 1998;23:259.
  • 14
    Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008;58:62330.
  • 15
    Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004;65:10419.
  • 16
    Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009;32:171620.
  • 17
    Panero F, Gruden G, Perotto M, Fornengo P, Barutta F, Greco E et al. Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. Atherosclerosis 2012;221:1838.
  • 18
    Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant 2009;24:12606.
  • 19
    Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:173942.
  • 20
    Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 1995;15:161624.
  • 21
    Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:15037.
  • 22
    Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008;28:118692.
  • 23
    Ndrepepa G, Braun S, King L, Hadamitzky M, Haase HU, Birkmeier KA et al. Association of uric acid with mortality in patients with stable coronary artery disease. Metabolism 2012;61:17806.
  • 24
    Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:3553.
  • 25
    Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193202.
  • 26
    Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968;75:32534.
  • 27
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:3141.
  • 28
    Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:234451.
  • 29
    Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:15772; discussion 207–12.
  • 30
    Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002;89:127.
  • 31
    Madsen TE, Muhlestein JB, Carlquist JF, Horne BD, Bair TL, Jackson JD et al. Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease. Am J Nephrol 2005;25:459.
  • 32
    Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:181121.
  • 33
    Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005;25:3942.
  • 34
    Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005;25:42533.
  • 35
    Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 2004;1:10.
  • 36
    De Scheerder IK, van de Kraay AM, Lamers JM, Koster JF, de Jong JW, Serruys PW. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation. Am J Cardiol 1991;68:3925.
  • 37
    Patetsios P, Song M, Shutze WP, Pappas C, Rodino W, Ramirez JA et al. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 2001;88:18891, A6.
  • 38
    Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295300.
  • 39
    Gaffo AL, Edwards NL, Saag KG. Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther 2009;11:240.
  • 40
    Lee SM, Lee AL, Winters TJ, Tam E, Jaleel M, Stenvinkel P et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 2009;29:7985.
  • 41
    Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY. Serum uric acid levels show a ‘J-shaped’ association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004;19:45762.
  • 42
    Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther 2008;324:17.
  • 43
    Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010;62:17080.
  • 44
    Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008;125:2329.
  • 45
    Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008;54:27384.
  • 46
    Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:130111.
  • 47
    Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol 2011;71:6007.
  • 48
    Rajendra NS, Ireland S, George J, Belch JJ, Lang CC, Struthers AD. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol 2011;58:8208.
  • 49
    Noman A, Ang DS, Ogston S, Lang CC, Struthers AD. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010;375:21617.